A little speculation on my part. I have followed several antisence companies and several apoptosis companies. I would buy Idun if it were publicly held. If and this is a long shot Isis and Idun had any synergies I would welcome them. If antisence can modulate certain forms of cell death pathways that IDUN has a patent protected understanding and they jointly develope novel treatments for degenerative neurological and cardiovascular diseases this would be huge. So let's not jump to conclusions on this just yet.